Entero Therapeutics, Inc. (ENTO) Stock
ENTO is no longer traded. Entero Therapeutics was delisted from the Nasdaq in January 2026.
Prices on this page are historical; the last trade was January 29, 2026 at $2.85.
Entero Therapeutics stock price history
ENTO final trading statistics
- Final close
- $2.85
- Final trading day
- Jan 29, 2026
- Market cap at delisting
- $9.58M
- Shares outstanding
- 3.36M
- Final 52-week range
- $0.32 – $5.84
- Avg. volume (final 3 mo.)
- 124,986
- All-time high (split-adj.)
- $690480.00 · Oct 2016
- All-time low (split-adj.)
- $0.71 · Aug 2024
- Return since IPO
- -100.0%
- Beta
- 1.15
- Book value / share
- -$3.96
- Price / book
- -0.72
Entero Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $0.00 | -$18.1M | -$12.90 |
| FY2023 | $0.00 | -$15.8M | -$161.74 |
| FY2022 | $0.00 | -$14.6M | -$11.11 |
| FY2021 | $0.00 | -$58.5M | -$6.54 |
| FY2020 | $0.00 | -$32.7M | -$1.44 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Entero Therapeutics, Inc.
Entero Therapeutics, Inc. designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. The company's Aggregation Management Platform leverages IoT, AI/ML, and edge analytics to forecast, optimize, and dispatch flexible demand. The company also engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. It serves residential and small business, commercial and utility, technology and innovation, and hyperscale industries. The company is based in Edinburgh, United Kingdom with additional offices in Prague, Czechia; and Mississauga, Canada.
Entero Therapeutics stock FAQ
What happened to Entero Therapeutics stock?
Entero Therapeutics stock was delisted from the Nasdaq. Its final close was $2.85 on January 29, 2026.
Is ENTO stock still trading?
No. ENTO was delisted from the Nasdaq in January 2026 and no longer trades on a U.S. exchange.
What was the last price of ENTO stock?
ENTO closed at $2.85 on its final trading day, January 29, 2026, for a market value of about $9.58M.
What were Entero Therapeutics's revenue and earnings in its last full fiscal year?
Entero Therapeutics reported revenue of $0.00 and net income of -$18.1M in fiscal 2024, its last full year as a public company.
When did Entero Therapeutics go public?
Entero Therapeutics, Inc. stock began trading on October 11, 2016.